drug

casdozokitug

1 story · latest Aug 5, 2026

Status: Investigational
Code: CHS-388
Trials: 2 registered trials in coverage

Relationships

Developed by Coherus Oncology, Inc.

Timeline

Coherus reports Q2 2026 results, flags October data update for tagmokitug

Aug 5Quarterly updateCoherus Oncology, Inc.toripalimab-tpzi

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.